关键数据
28.790今开
29.310最高
770.28K成交量
亏损市盈率 TTM
7.00市盈率动
--股息TTM
1.34%换手率
29.300昨收
28.216最低
12.32M成交额
亏损市盈率静
1.14市净率
0.00%股息率 TTM
-26.06%ROA
38.19052周最高
0.79量比
-825.49M净利润
57.55M总股本
-19.9221每股收益TTM
1.23Beta
-55.46%ROE
21.00052周最低
3.73%振幅
54.92%毛利率
1.68B总市值
3.95回报/风险
3.32%风险率
操作建议
Enovis Corp当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名28/199位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价41.92。中期看,股价处于上升通道。近一个月,市场表现较强,基本面评分较高,但较强的走势得没有得到技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Enovis Corp新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Enovis Corp简介
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
公司代码ENOV
公司Enovis Corp
CEOMcdonald (Damien)
网址https://www.enovis.com/
公司股东
常见问题
Enovis Corp(ENOV)的当前股价是多少?
Enovis Corp(ENOV)的当前股价是 29.15。
Enovis Corp股票的52周最高点是多少?
Enovis Corp股票的52周最高点是38.19。
Enovis Corp股票的52周最低点是多少?
Enovis Corp股票的52周最低点是21.00。
现在Enovis Corp(ENOV)的股票是买入、持有还是卖出?
根据分析师评级,Enovis Corp(ENOV)的总体评级为买入,目标价格为41.92。
Enovis Corp(ENOV)股票的每股收益(EPS TTM)是多少
Enovis Corp(ENOV)股票的每股收益(EPS TTM)是-20.75。